117 related articles for article (PubMed ID: 32307656)
1. The impact of surgery refusal on thyroid cancer survival: a SEER-based analysis.
van Gerwen M; Sinclair C; Rahman M; Genden E; Taioli E
Endocrine; 2020 Nov; 70(2):356-363. PubMed ID: 32307656
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit of active surveillance for papillary thyroid carcinoma: a propensity score matching analysis based on SEER database.
Bi J; Lyu PF; Wang Y; Zhang H
Front Oncol; 2023; 13():1185650. PubMed ID: 37361590
[TBL] [Abstract][Full Text] [Related]
3. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
[No Abstract] [Full Text] [Related]
4. Management of Very Elderly Patients With Papillary Thyroid Cancer: Analysis of Outcomes for Surgery Versus Nonsurgery.
Zhou J; Tan J; Ming J; Guo H; Li X; Zhang N; Huang T
J Surg Res; 2020 Dec; 256():512-519. PubMed ID: 32798999
[TBL] [Abstract][Full Text] [Related]
5. Delay in Surgery and Papillary Thyroid Cancer Survival in the United States: A SEER-Medicare Analysis.
Chaves N; Broekhuis JM; Fligor SC; Collins RA; Modest AM; Kaul S; James BC
J Clin Endocrinol Metab; 2023 Sep; 108(10):2589-2596. PubMed ID: 36987566
[TBL] [Abstract][Full Text] [Related]
6. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
[TBL] [Abstract][Full Text] [Related]
7. Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage.
Zambeli-Ljepović A; Wang F; Dinan MA; Hyslop T; Roman SA; Sosa JA; Scheri RP
J Surg Res; 2019 Nov; 243():189-197. PubMed ID: 31185435
[TBL] [Abstract][Full Text] [Related]
8. Surgery for papillary thyroid carcinoma: is lobectomy enough?
Mendelsohn AH; Elashoff DA; Abemayor E; St John MA
Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1055-61. PubMed ID: 21079156
[TBL] [Abstract][Full Text] [Related]
9. Impact of Age on the Prognosis of Papillary Thyroid Carcinoma.
Sun Y; Dai W; Liang Y; Xia N
Arch Iran Med; 2020 Mar; 23(3):169-174. PubMed ID: 32126785
[TBL] [Abstract][Full Text] [Related]
10. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
Oyer SL; Fritsch VA; Lentsch EJ
Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
[TBL] [Abstract][Full Text] [Related]
11. Sex is not an independent risk factor for survival in differentiated thyroid cancer.
Oyer SL; Smith VA; Lentsch EJ
Laryngoscope; 2013 Nov; 123(11):2913-9. PubMed ID: 23564257
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant external beam radiotherapy for locally invasive papillary thyroid cancer.
Megwalu UC; Orloff LA; Ma Y
Head Neck; 2019 Jun; 41(6):1719-1724. PubMed ID: 30620424
[TBL] [Abstract][Full Text] [Related]
13. Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: Comparative analysis after propensity score matching: A multicenter study.
Kuba S; Yamanouchi K; Hayashida N; Maeda S; Adachi T; Sakimura C; Kawakami F; Yano H; Matsumoto M; Otsubo R; Sato S; Fujioka H; Kuroki T; Nagayasu T; Eguchi S
Int J Surg; 2017 Feb; 38():143-148. PubMed ID: 27677707
[TBL] [Abstract][Full Text] [Related]
14. Association of adjuvant radioactive iodine therapy with survival in node-positive papillary thyroid cancer.
Sun Y; Gong J; Guo B; Shang J; Cheng Y; Xu H
Oral Oncol; 2018 Dec; 87():152-157. PubMed ID: 30527231
[TBL] [Abstract][Full Text] [Related]
15. Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
Kauffmann RM; Hamner JB; Ituarte PHG; Yim JH
BMC Cancer; 2018 Mar; 18(1):316. PubMed ID: 29566662
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of FTC compared to PTC and FVPTC: findings based on SEER database using propensity score matching analysis.
Liu Z; Zeng W; Huang L; Wang Z; Wang M; Zhou L; Chen D; Feng H; Zhou W; Guo L
Am J Cancer Res; 2018; 8(8):1440-1448. PubMed ID: 30210915
[TBL] [Abstract][Full Text] [Related]
17. Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database.
Smith VA; Sessions RB; Lentsch EJ
J Surg Oncol; 2012 Sep; 106(4):357-62. PubMed ID: 22392921
[TBL] [Abstract][Full Text] [Related]
18. Multifocality Is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score-Matching Analysis.
Geron Y; Benbassat C; Shteinshneider M; Or K; Markus E; Hirsch D; Levy S; Ziv-Baran T; Muallem-Kalmovich L
Thyroid; 2019 Apr; 29(4):513-522. PubMed ID: 30799769
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent changes in the prognostic advantage of papillary thyroid cancer in women: A SEER-based study.
Liu Q; Ma B; Song M; Sun W; Zhang H
Clin Endocrinol (Oxf); 2023 Sep; 99(3):342-349. PubMed ID: 36806120
[TBL] [Abstract][Full Text] [Related]
20. UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.
Liu YQ; Li H; Liu JR; Lin YS
Endocr Pract; 2019 Dec; 25(12):1286-1294. PubMed ID: 31412228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
